{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T05:39:40Z","timestamp":1731476380840,"version":"3.28.0"},"reference-count":19,"publisher":"Georg Thieme Verlag KG","issue":"04","license":[{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":105,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP Rep"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>In recent times, atypical antipsychotics are increasingly being used in the neonatal intensive care unit (NICU) for the management of neonatal delirium. As the recognition of delirium in NICU infants increases, caution should be exercised with use of antipsychotics for management, given associated adverse effects. Neuroleptic malignant syndrome (NMS) is a rare adverse drug reaction associated with exposure to antipsychotics and other antidopaminergic medications. Most reported cases of NMS in pediatric patients have been in older children on antipsychotic medications. We present a case of a 10-month-old former preterm infant who developed clinical signs suggestive of NMS after exposure to olanzapine for treatment of delirium. Our case report details the clinical course of this infant, delves into the condition, and outlines some useful lessons for the clinician in the identification and management of this rare but life-threatening adverse effect.<\/jats:p><jats:p>\n            Key Points\n          <\/jats:p>","DOI":"10.1055\/a-2441-4217","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T23:07:32Z","timestamp":1728947252000},"page":"e259-e261","source":"Crossref","is-referenced-by-count":0,"title":["Neuroleptic Malignant Syndrome in a 10-Month-Old Ex-Preterm Infant with Delirium"],"prefix":"10.1055","volume":"14","author":[{"given":"Gloria","family":"Akuamoah-Boateng","sequence":"additional","affiliation":[{"name":"Department of Pediatrics-Division of Neonatology, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla A.","family":"Buttafuoco","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney C.","family":"Sutton","sequence":"additional","affiliation":[{"name":"Department of Pharmacy-Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian P.","family":"Hackett","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/1941875210386491","article-title":"Neuroleptic malignant syndrome: a review for neurohospitalists","volume":"1","author":"B D Berman","year":"2011","journal-title":"Neurohospitalist"},{"issue":"02","key":"ref2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1212\/WNL.31.2.132","article-title":"Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?","volume":"31","author":"V W Henderson","year":"1981","journal-title":"Neurology"},{"issue":"02","key":"ref3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.7150\/ijms.10453","article-title":"Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database","volume":"12","author":"G Kimura","year":"2015","journal-title":"Int J Med Sci"},{"issue":"01","key":"ref4","first-page":"84","article-title":"An approach to the pharmacotherapy of neuroleptic malignant syndrome","volume":"49","author":"R van Rensburg","year":"2019","journal-title":"Psychopharmacol Bull"},{"issue":"07","key":"ref5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4088\/JCP.v69n0716","article-title":"Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases","volume":"69","author":"P E Croarkin","year":"2008","journal-title":"J Clin Psychiatry"},{"issue":"04","key":"ref6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/cap.2008.0130","article-title":"Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review","volume":"19","author":"R Neuhut","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"05","key":"ref7","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/JCP.0000000000001749","article-title":"Neuroleptic malignant syndrome in a 15-month-old child: a case report","volume":"43","author":"A J Penugonda","year":"2023","journal-title":"J Clin Psychopharmacol"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0733-8627(05)70127-9","article-title":"The neuroleptic malignant and serotonin syndromes","volume":"18","author":"J R Carbone","year":"2000","journal-title":"Emerg Med Clin North Am"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.jcp.0000270093.39909.a9","article-title":"Late-onset neuroleptic malignant syndrome in a patient using olanzapine","volume":"27","author":"M Kunz","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"06","key":"ref10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1176\/ajp.2007.164.6.870","article-title":"Neuroleptic malignant syndrome","volume":"164","author":"J R Strawn","year":"2007","journal-title":"Am J Psychiatry"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0379-0738(00)00323-6","article-title":"An autopsy case of neuroleptic malignant syndrome (NMS) and its immunohistochemical findings of muscle-associated proteins and mitochondria","volume":"115","author":"S Kubo","year":"2001","journal-title":"Forensic Sci Int"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1176\/jnp.7.2.135","article-title":"Neuroleptic malignant syndrome and malignant hyperthermia: end of a controversy?","volume":"7","author":"P E Keck Jr","year":"1995","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"02","key":"ref13","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/20009666.2020.1742522","article-title":"A rare association of Takotsubo cardiomyopathy with neuroleptic malignant syndrome","volume":"10","author":"W Ullah","year":"2020","journal-title":"J Community Hosp Intern Med Perspect"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4088\/JCP.v65n0403","article-title":"Neuroleptic malignant syndrome and atypical antipsychotic drugs","volume":"65","author":"J Ananth","year":"2004","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2169\/internalmedicine.43.1162","article-title":"Reversible cardiomyopathy as the autonomic involvement of neuroleptic malignant syndrome","volume":"43","author":"M Oomura","year":"2004","journal-title":"Intern Med"},{"issue":"01","key":"ref16","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2165\/00002018-199819010-00006","article-title":"Neuroleptic malignant syndrome. Recognition, prevention and management","volume":"19","author":"V R Velamoor","year":"1998","journal-title":"Drug Saf"},{"issue":"09","key":"ref17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1176\/ps.49.9.1163","article-title":"Neuroleptic malignant syndrome: a review","volume":"49","author":"A L Pelonero","year":"1998","journal-title":"Psychiatr Serv"},{"key":"ref18","first-page":"95","volume-title":"Neuroleptic malignant syndrome","author":"S N Caroff","year":"2022"},{"issue":"03","key":"ref19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/15563650601031692","article-title":"Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl","volume":"45","author":"S Erermis","year":"2007","journal-title":"Clin Toxicol (Phila)"}],"container-title":["American Journal of Perinatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2441-4217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:23:34Z","timestamp":1731457414000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2441-4217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":19,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2024,10,11]]},"published-print":{"date-parts":[[2024,7]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2441-4217","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2157-6998","2157-7005"],"issn-type":[{"type":"print","value":"2157-6998"},{"type":"electronic","value":"2157-7005"}],"subject":[],"published-other":{"date-parts":[[2024,10,14]]},"published":{"date-parts":[[2024,7]]}}}